FI970331L - Pharmaceutical delivery composition for nasal administration of antiviral agents - Google Patents

Pharmaceutical delivery composition for nasal administration of antiviral agents Download PDF

Info

Publication number
FI970331L
FI970331L FI970331A FI970331A FI970331L FI 970331 L FI970331 L FI 970331L FI 970331 A FI970331 A FI 970331A FI 970331 A FI970331 A FI 970331A FI 970331 L FI970331 L FI 970331L
Authority
FI
Finland
Prior art keywords
antiviral agents
nasal administration
delivery composition
pharmaceutical delivery
pharmaceutical
Prior art date
Application number
FI970331A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970331A7 (en
FI970331A0 (en
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI970331A7 publication Critical patent/FI970331A7/en
Publication of FI970331L publication Critical patent/FI970331L/en
Publication of FI970331A0 publication Critical patent/FI970331A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Tires In General (AREA)
  • Tyre Moulding (AREA)
FI970331A 1994-07-26 1995-07-24 The drug administration composition for nasal administration FI970331A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414966A GB9414966D0 (en) 1994-07-26 1994-07-26 Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en) 1994-07-26 1995-07-24 Drug delivery composition for the nasal administration of antiviral agents

Publications (3)

Publication Number Publication Date
FI970331A7 FI970331A7 (en) 1997-01-27
FI970331L true FI970331L (en) 1997-01-27
FI970331A0 FI970331A0 (en) 1997-01-27

Family

ID=10758832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970331A FI970331A0 (en) 1994-07-26 1995-07-24 The drug administration composition for nasal administration

Country Status (7)

Country Link
EP (1) EP0773791A1 (en)
JP (1) JPH10506376A (en)
CA (1) CA2195639A1 (en)
FI (1) FI970331A0 (en)
GB (2) GB9414966D0 (en)
NO (1) NO970252D0 (en)
WO (1) WO1996003142A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929096T2 (en) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Human rhinovirus receptor protein that inhibits susceptibility to virus infection
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
US6365343B1 (en) * 1996-03-06 2002-04-02 Boehringer Ingelheim Pharmaceuticals, Inc. Intercellular adhesion molecule powder formulation
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
WO1999003452A1 (en) * 1997-07-18 1999-01-28 Bayer Corporation Methods of removing residual solvent from nasal drug delivery compositions
CA2308291A1 (en) * 1997-10-31 1999-05-14 Thierry Nivaggioli Controlled release compositions comprising gellan gum gels
DK1035833T3 (en) * 1997-12-02 2006-01-09 Archimedes Dev Ltd Composition for nasal administration
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
RU2185822C2 (en) * 2000-08-01 2002-07-27 Общество с ограниченной ответственностью "Фармаген" Preparation for treatment and prophylaxis of viral diseases
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
DE102008007759B4 (en) 2007-12-04 2009-09-24 Atlantichem Gmbh Agent for preventing discoloration when washing textiles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ES2064327T3 (en) * 1987-11-02 1995-02-01 Baylor College Medicine USE OF ICAM-1 OR ITS FUNCTIONAL DERIVATIVES FOR THE TREATMENT OF NON-SPECIFIC INFLAMMATION.
DE68929096T2 (en) * 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Human rhinovirus receptor protein that inhibits susceptibility to virus infection
SE8804164A0 (en) * 1988-11-17 1990-05-18 Per Prisell Pharmaceutical preparation
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
WO1993006842A1 (en) * 1991-10-02 1993-04-15 Boehringer Ingelheim Pharmaceuticals, Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
EP0604624A4 (en) * 1992-06-22 1997-03-12 Miles Inc Multimeric forms of human rhinovirus receptor protein.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
GB9414966D0 (en) 1994-09-14
NO970252L (en) 1997-01-21
EP0773791A1 (en) 1997-05-21
FI970331A7 (en) 1997-01-27
GB2305606A (en) 1997-04-16
AU707462B2 (en) 1999-07-08
GB2305606B (en) 1998-08-05
AU2988695A (en) 1996-02-22
WO1996003142A1 (en) 1996-02-08
FI970331A0 (en) 1997-01-27
CA2195639A1 (en) 1996-02-08
JPH10506376A (en) 1998-06-23
NO970252D0 (en) 1997-01-21
GB9700817D0 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
NO20002851D0 (en) Compositions for nasal administration of drugs
MX9101175A (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
FI955583A7 (en) Nasal drug delivery composition containing nicotine
FI970331L (en) Pharmaceutical delivery composition for nasal administration of antiviral agents
GB2303064B (en) Medicament for nasal administration
ITMI910436A0 (en) NASAL DISPENSER OF NEBULIZED PHARMACEUTICAL SUBSTANCES
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
NO20003161D0 (en) Compositions for nasal administration of cannabinoids
FI944123L (en) Pharmaceutical inhalation compositions
FI972579L (en) Intravaginal drug delivery devices for the administration of 17 beta-estradiol precursors
FI980822A7 (en) Pharmaceutical composition for the delivery of an active ingredient to or through the skin or mucosal surface
ITRM910922A1 (en) ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
FI955310L (en) Pharmaceutical composition for oral administration of flavonoids
NO950134D0 (en) Formulations for orally administered pharmaceutical agents
IT9019112A1 (en) PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN
IT1223132B (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
ITBS920130A0 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES
ITMI913306A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION OF POLYPEPTIDES
ITMI940562A0 (en) PHARMACEUTICAL COMPOSITIONS OF CALCITONIN FOR RECTAL ADMINISTRATION
IT8819541A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
ITMI920214A0 (en) STABLE PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF CALCITONIN
IT9021264A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE INTRANASAL ADMINISTRATION OF CALCITONIN
ITPD920141A0 (en) PHARMACEUTICAL FORMULATION FOR THE ORAL ADMINISTRATION OF CALCITONI-NA
NO920647L (en) NASAL PHARMACEUTICAL PREPARATION

Legal Events

Date Code Title Description
MA Patent expired